Advanced Medical Isotope Price to Free Cash Flow Ratio 2013-2025 | RDGL
Historical price to free cash flow ratio values for Advanced Medical Isotope (RDGL) since 2013.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Advanced Medical Isotope Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-07-24 | 0.13 | 0.00 | |
| 2025-03-31 | 0.12 | $0.00 | 0.00 |
| 2024-12-31 | 0.11 | $0.00 | 0.00 |
| 2024-09-30 | 0.16 | $0.00 | 0.00 |
| 2024-06-30 | 0.20 | $0.00 | 0.00 |
| 2024-03-31 | 0.07 | $0.00 | 0.00 |
| 2023-12-31 | 0.07 | $0.00 | 0.00 |
| 2023-09-30 | 0.07 | $0.00 | 0.00 |
| 2023-06-30 | 0.05 | $0.00 | 0.00 |
| 2023-03-31 | 0.07 | $0.00 | 0.00 |
| 2022-12-31 | 0.04 | $0.00 | 0.00 |
| 2022-09-30 | 0.05 | $0.00 | 0.00 |
| 2022-06-30 | 0.07 | $0.00 | 0.00 |
| 2022-03-31 | 0.07 | $0.00 | 0.00 |
| 2021-12-31 | 0.08 | $0.00 | 0.00 |
| 2021-09-30 | 0.12 | $0.00 | 0.00 |
| 2021-06-30 | 0.12 | $0.00 | 0.00 |
| 2021-03-31 | 0.10 | $0.00 | 0.00 |
| 2020-12-31 | 0.11 | $0.00 | 0.00 |
| 2020-09-30 | 0.03 | $0.00 | 0.00 |
| 2020-06-30 | 0.04 | $0.00 | 0.00 |
| 2020-03-31 | 0.03 | $0.00 | 0.00 |
| 2019-12-31 | 0.04 | $0.00 | 0.00 |
| 2019-09-30 | 0.04 | $-0.01 | 0.00 |
| 2019-06-30 | 0.03 | $-0.01 | 0.00 |
| 2019-03-31 | 0.02 | $-0.01 | 0.00 |
| 2018-12-31 | 0.06 | $-0.01 | 0.00 |
| 2018-09-30 | 0.14 | $-0.05 | 0.00 |
| 2018-06-30 | 0.02 | $-0.09 | 0.00 |
| 2018-03-31 | 0.24 | $-0.16 | 0.00 |
| 2017-12-31 | 0.40 | $-0.21 | 0.00 |
| 2017-09-30 | 0.57 | $-0.23 | 0.00 |
| 2017-06-30 | 0.66 | $-0.26 | 0.00 |
| 2017-03-31 | 1.21 | $-0.54 | 0.00 |
| 2016-12-31 | 1.40 | $-0.72 | 0.00 |
| 2016-09-30 | 1.68 | $-0.90 | 0.00 |
| 2016-06-30 | 2.96 | $-0.85 | 0.00 |
| 2016-03-31 | 3.76 | $-0.62 | 0.00 |
| 2015-12-31 | 1.84 | $-0.52 | 0.00 |
| 2015-09-30 | 1.12 | $-0.35 | 0.00 |
| 2015-06-30 | 0.72 | $1.31 | 0.55 |
| 2015-03-31 | 2.80 | $0.24 | 11.74 |
| 2014-12-31 | 0.72 | $-2.85 | 0.00 |
| 2014-09-30 | 2.88 | $-4.44 | 0.00 |
| 2014-06-30 | 17.52 | $-8.34 | 0.00 |
| 2014-03-31 | 39.84 | $-14.31 | 0.00 |
| 2013-12-31 | 50.40 | $-16.18 | 0.00 |
| 2013-09-30 | 38.40 | $-17.38 | 0.00 |
| 2013-06-30 | 48.00 | $-22.78 | 0.00 |
| 2013-03-31 | 100.80 | $3,298.27 | 0.03 |
| 2012-12-31 | 148.00 | $-19.03 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Finance | Finance - SBIC & Commercial | $0.060B | $0.000B |
| Vivos Inc. is a late stage development company. It engaged primarily in the development of brachytherapy devices for therapeutic applications. Vivos Inc., formerly known as Advanced Medical Isotope Corporation, is based in Richland, Washington. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ares Capital (ARCC) | United States | $15.987B | 10.28 |
| Blackstone Secured Lending Fund (BXSL) | United States | $7.451B | 9.35 |
| Blue Owl Technology Finance (OTF) | United States | $7.209B | 0.00 |
| Main Street Capital (MAIN) | United States | $5.838B | 16.23 |
| Golub Capital BDC (GBDC) | United States | $4.092B | 8.88 |
| Hercules Capital (HTGC) | United States | $3.409B | 9.91 |
| Sixth Street Specialty Lending (TSLX) | United States | $2.293B | 10.43 |
| Morgan Stanley Direct Lending Fund (MSDL) | United States | $1.724B | 8.24 |
| Goldman Sachs BDC (GSBD) | United States | $1.396B | 5.86 |
| New Mountain Finance (NMFC) | United States | $1.146B | 7.93 |
| Kayne Anderson BDC (KBDC) | United States | $1.126B | 8.31 |
| BARINGS BDC, INC (BBDC) | United States | $1.009B | 7.84 |
| Bain Capital Specialty Finance (BCSF) | United States | $0.996B | 7.46 |
| Trinity Capital (TRIN) | United States | $0.971B | 7.12 |
| Amalgamated Financial (AMAL) | United States | $0.933B | 8.55 |
| Nuveen Churchill Direct Lending (NCDL) | United States | $0.851B | 7.56 |
| Fidus Investment (FDUS) | United States | $0.745B | 9.50 |
| Carlyle Secured Lending (CGBD) | United States | $0.711B | 7.43 |
| BLACKROCK TCP CAPITAL CORP (TCPC) | United States | $0.646B | 5.00 |
| Gladstone Capital (GLAD) | United States | $0.639B | 13.82 |
| CION Investment (CION) | United States | $0.534B | 6.58 |
| Gladstone Investment (GAIN) | United States | $0.518B | 14.49 |
| PennantPark Investment (PNNT) | United States | $0.483B | 8.80 |
| Palmer Square Capital BDC (PSBD) | United States | $0.453B | 7.69 |
| Stellus Capital Investment (SCM) | United States | $0.419B | 9.00 |
| Runway Growth Finance (RWAY) | United States | $0.413B | 6.95 |
| Saratoga Investment Corp (SAR) | United States | $0.397B | 7.34 |
| Horizon Technology Finance (HRZN) | United States | $0.340B | 6.90 |
| TriplePoint Venture Growth BDC (TPVG) | United States | $0.289B | 5.65 |
| Chicago Atlantic BDC (LIEN) | United States | $0.235B | 39.65 |
| Medallion Financial (MFIN) | United States | $0.223B | 6.00 |
| WhiteHorse Finance (WHF) | United States | $0.207B | 6.27 |
| Oxford Square Capital (OXSQ) | United States | $0.176B | 5.63 |
| PhenixFIN (PFX) | United States | $0.099B | 19.55 |
| Rand Capital (RAND) | United States | $0.055B | 10.56 |
| Investcorp Credit Management BDC (ICMB) | United States | $0.041B | 8.20 |
| SLR Investment (SLRC) | United States | $0.000B | 9.35 |
| OFS Capital (OFS) | United States | $0.000B | 7.77 |
| FS KKR Capital (FSK) | United States | $0.000B | 7.95 |
| Crescent Capital BDC (CCAP) | United States | $0.000B | 6.62 |